Melphalan (Mel)

DRUG2 trials

Sponsors

Technische Universität Dresden, Institute of Hematology & Blood Diseases Hospital, China

Conditions

AML - Acute Myeloid LeukemiaAplastic Anemia IdiopathicMDS (Myelodysplastic Syndrome)

Phase 2

Evaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in Patients With AML and MDS Undergoing Allogeneic Transplantation

RecruitingNCT07025824

Technische Universität DresdenAML - Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome)

Start: 2026-01-21End: 2029-09-01Target: 220Updated: 2026-09-02

Efficacy and Safety of UCBT With TMI -Based Conditioning Regimen for Adults With Refractory/Relapsed Aplastic Anemia

Not yet recruitingNCT07078721

Institute of Hematology & Blood Diseases Hospital, ChinaAplastic Anemia Idiopathic

Start: 2025-07-20End: 2028-06-30Target: 11Updated: 2025-07-22